Please assess the completion status of the following clinical trial:

Trial Title: Calcineurin Activity in Renal Recipients

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* adult renal transplant recipients~* treated by tacrolimus (Prograf or ADVAGRAF), corticoids, Cellcept,~Exclusion Criteria:~* patients with a high risk of bad compliance (toxicomania, severe psychiatric troubles)~* multiorgan transplant patients with mTOR inhibitors treatments~* HIV infected patients~* lack of consent for this study

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Tacrolimus (Type: NO_INTERVENTION): Determination of tacrolimus concentrations in whole blood and of calcineurin activities in lymphocytes at D8, D15, D21 (pharmacokinetics on 4 times samples), D28, M2 and M3 (residual measurement)

Based on this trial design, predict the completion outcome and termination type (if applicable).